These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22189840)

  • 21. Copy number polymorphisms near SLC2A9 are associated with serum uric acid concentrations.
    Scharpf RB; Mireles L; Yang Q; Köttgen A; Ruczinski I; Susztak K; Halper-Stromberg E; Tin A; Cristiano S; Chakravarti A; Boerwinkle E; Fox CS; Coresh J; Linda Kao WH
    BMC Genet; 2014 Jul; 15():81. PubMed ID: 25007794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significant association of serum uric acid levels with SLC2A9 rs11722228 among a Japanese population.
    Hamajima N; Okada R; Kawai S; Hishida A; Morita E; Yin G; Wakai K; Matsuo H; Inoue H; Takada Y; Asai Y; Mori A; Naito M
    Mol Genet Metab; 2011 Aug; 103(4):378-82. PubMed ID: 21511506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions between genetic variants in glucose transporter type 9 (SLC2A9) and dietary habits in serum uric acid regulation.
    Jeroncić I; Mulić R; Klismanić Z; Rudan D; Boban M; Zgaga L
    Croat Med J; 2010 Feb; 51(1):40-7. PubMed ID: 20162744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CYP4A11 T8590C polymorphism, salt-sensitive hypertension, and renal blood flow.
    Williams JS; Hopkins PN; Jeunemaitre X; Brown NJ
    J Hypertens; 2011 Oct; 29(10):1913-8. PubMed ID: 21873888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Serum Uric Acid with Metabolic Syndrome and Its Components: A Mendelian Randomization Analysis.
    Wang L; Zhang T; Liu Y; Tang F; Xue F
    Biomed Res Int; 2020; 2020():6238693. PubMed ID: 32258131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex and age interaction with genetic association of atherogenic uric acid concentrations.
    Brandstätter A; Lamina C; Kiechl S; Hunt SC; Coassin S; Paulweber B; Kramer F; Summerer M; Willeit J; Kedenko L; Adams TD; Kronenberg F
    Atherosclerosis; 2010 Jun; 210(2):474-8. PubMed ID: 20053405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SLC2A9 Genotype Is Associated with SLC2A9 Gene Expression and Urinary Uric Acid Concentration.
    Ware EB; Riehle E; Smith JA; Zhao W; Turner ST; Kardia SL; Lieske JC
    PLoS One; 2015; 10(7):e0128593. PubMed ID: 26167684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Homozygous SLC2A9 mutations cause severe renal hypouricemia.
    Dinour D; Gray NK; Campbell S; Shu X; Sawyer L; Richardson W; Rechavi G; Amariglio N; Ganon L; Sela BA; Bahat H; Goldman M; Weissgarten J; Millar MR; Wright AF; Holtzman EJ
    J Am Soc Nephrol; 2010 Jan; 21(1):64-72. PubMed ID: 19926891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Xanthine oxidase gene variants and their association with blood pressure and incident hypertension: a population study.
    Scheepers LE; Wei FF; Stolarz-Skrzypek K; Malyutina S; Tikhonoff V; Thijs L; Salvi E; Barlassina C; Filipovský J; Casiglia E; Nikitin Y; Kawecka-Jaszcz K; Manunta P; Cusi D; Boonen A; Staessen JA; Arts IC
    J Hypertens; 2016 Nov; 34(11):2147-54. PubMed ID: 27607461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of a polymorphism in a gene encoding a urate transporter with CKD progression.
    Testa A; Mallamaci F; Spoto B; Pisano A; Sanguedolce MC; Tripepi G; Leonardis D; Zoccali C
    Clin J Am Soc Nephrol; 2014 Jun; 9(6):1059-65. PubMed ID: 24742479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bayesian methods for instrumental variable analysis with genetic instruments ('Mendelian randomization'): example with urate transporter SLC2A9 as an instrumental variable for effect of urate levels on metabolic syndrome.
    McKeigue PM; Campbell H; Wild S; Vitart V; Hayward C; Rudan I; Wright AF; Wilson JF
    Int J Epidemiol; 2010 Jun; 39(3):907-18. PubMed ID: 20348110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo-Controlled Study.
    Gunawardhana L; McLean L; Punzi HA; Hunt B; Palmer RN; Whelton A; Feig DI
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29102979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between serum uric acid related genetic loci and diabetic kidney disease in the Chinese type 2 diabetes patients.
    Yan D; Wang J; Jiang F; Zhang R; Sun X; Wang T; Wang S; Peng D; He Z; Bao Y; Hu C; Jia W
    J Diabetes Complications; 2016 Jul; 30(5):798-802. PubMed ID: 26993665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variation in the uric acid transporter gene SLC2A9 and its association with AAO of Parkinson's disease.
    Facheris MF; Hicks AA; Minelli C; Hagenah JM; Kostic V; Campbell S; Hayward C; Volpato CB; Pattaro C; Vitart V; Wright A; Campbell H; Klein C; Pramstaller PP
    J Mol Neurosci; 2011 Mar; 43(3):246-50. PubMed ID: 20589538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of common polymorphisms in GLUT9 gene with gout but not with coronary artery disease in a large case-control study.
    Stark K; Reinhard W; Neureuther K; Wiedmann S; Sedlacek K; Baessler A; Fischer M; Weber S; Kaess B; Erdmann J; Schunkert H; Hengstenberg C
    PLoS One; 2008 Apr; 3(4):e1948. PubMed ID: 18398472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The serum uric acid concentration is not causally linked to diabetic nephropathy in type 1 diabetes.
    Ahola AJ; Sandholm N; Forsblom C; Harjutsalo V; Dahlström E; Groop PH;
    Kidney Int; 2017 May; 91(5):1178-1185. PubMed ID: 28238338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two novel homozygous SLC2A9 mutations cause renal hypouricemia type 2.
    Dinour D; Gray NK; Ganon L; Knox AJ; Shalev H; Sela BA; Campbell S; Sawyer L; Shu X; Valsamidou E; Landau D; Wright AF; Holtzman EJ
    Nephrol Dial Transplant; 2012 Mar; 27(3):1035-41. PubMed ID: 21810765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term effects of the SLC2A9 G844A and SLC22A12 C246T variants on serum uric acid concentrations in children.
    Lee HA; Park BH; Park EA; Cho SJ; Kim HS; Park H
    BMC Pediatr; 2018 Sep; 18(1):296. PubMed ID: 30189835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergism between asymmetric dimethylarginine (ADMA) and a genetic marker of uric acid in CKD progression.
    Testa A; Mallamaci F; Leonardis D; Spoto B; Pisano A; Sanguedolce MC; Tripepi G; Zoccali C;
    Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):167-72. PubMed ID: 25435339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variation in the uric acid transporter gene (SLC2A9) and memory performance.
    Houlihan LM; Wyatt ND; Harris SE; Hayward C; Gow AJ; Marioni RE; Strachan MW; Price JF; Starr JM; Wright AF; Deary IJ
    Hum Mol Genet; 2010 Jun; 19(11):2321-30. PubMed ID: 20197412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.